According to this study, Global Metabotropic Glutamate Receptor 3 market size will reach US$ million by 2031.

Global Metabotropic Glutamate Receptor 3 Market Size and Outlook 2025-31

According to this study, the global Metabotropic Glutamate Receptor 3 market size will reach US$ million by 2031. United States market for Metabotropic Glutamate Receptor 3 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Metabotropic Glutamate Receptor 3 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Metabotropic Glutamate Receptor 3 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Metabotropic Glutamate Receptor 3 players cover Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Denovo Biopharma LLC, Domain Therapeutics SA, Eli Lilly and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. LPI (LP Information) newest research report, the Metabotropic Glutamate Receptor 3 Industry Forecast looks at past sales and reviews total world Metabotropic Glutamate Receptor 3 sales in 2024, providing a comprehensive analysis by region and market sector of projected Metabotropic Glutamate Receptor 3 sales for 2025 through 2031. With Metabotropic Glutamate Receptor 3 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metabotropic Glutamate Receptor 3 industry. This Insight Report provides a comprehensive analysis of the global Metabotropic Glutamate Receptor 3 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Metabotropic Glutamate Receptor 3 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Metabotropic Glutamate Receptor 3 market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metabotropic Glutamate Receptor 3 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metabotropic Glutamate Receptor 3. This report presents a comprehensive overview, market shares, and growth opportunities of Metabotropic Glutamate Receptor 3 market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; LY-3020371 &nbsp;&nbsp;&nbsp; VU-0092273 &nbsp;&nbsp;&nbsp; DT-010991 &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Autism &nbsp;&nbsp;&nbsp; Chronic Pain &nbsp;&nbsp;&nbsp; Glioma &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Addex Therapeutics Ltd &nbsp;&nbsp;&nbsp; Aevi Genomic Medicine Inc &nbsp;&nbsp;&nbsp; Denovo Biopharma LLC &nbsp;&nbsp;&nbsp; Domain Therapeutics SA &nbsp;&nbsp;&nbsp; Eli Lilly and Company &nbsp;&nbsp;&nbsp; Prexton Therapeutics SA

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Metabotropic Glutamate Receptor 3 Market Size (2020-2031) &nbsp;2.1.2 Metabotropic Glutamate Receptor 3 Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Metabotropic Glutamate Receptor 3 by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Metabotropic Glutamate Receptor 3 Segment by Type &nbsp;2.2.1 LY-3020371 &nbsp;2.2.2 VU-0092273 &nbsp;2.2.3 DT-010991 &nbsp;2.2.4 Others &nbsp;2.3 Metabotropic Glutamate Receptor 3 Market Size by Type &nbsp;2.3.1 Metabotropic Glutamate Receptor 3 Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Type (2020-2025) &nbsp;2.4 Metabotropic Glutamate Receptor 3 Segment by Application &nbsp;2.4.1 Autism &nbsp;2.4.2 Chronic Pain &nbsp;2.4.3 Glioma &nbsp;2.4.4 Others &nbsp;2.5 Metabotropic Glutamate Receptor 3 Market Size by Application &nbsp;2.5.1 Metabotropic Glutamate Receptor 3 Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Metabotropic Glutamate Receptor 3 Market Size Market Share by Application (2020-2025) 3 Metabotropic Glutamate Receptor 3 Market Size by Player &nbsp;3.1 Metabotropic Glutamate Receptor 3 Market Size Market Share by Player &nbsp;3.1.1 Global Metabotropic Glutamate Receptor 3 Revenue by Player (2020-2025) &nbsp;3.1.2 Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Metabotropic Glutamate Receptor 3 Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Metabotropic Glutamate Receptor 3 by Region &nbsp;4.1 Metabotropic Glutamate Receptor 3 Market Size by Region (2020-2025) &nbsp;4.2 Global Metabotropic Glutamate Receptor 3 Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Metabotropic Glutamate Receptor 3 Market Size Growth (2020-2025) &nbsp;4.4 APAC Metabotropic Glutamate Receptor 3 Market Size Growth (2020-2025) &nbsp;4.5 Europe Metabotropic Glutamate Receptor 3 Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Metabotropic Glutamate Receptor 3 Market Size by Country (2020-2025) &nbsp;5.2 Americas Metabotropic Glutamate Receptor 3 Market Size by Type (2020-2025) &nbsp;5.3 Americas Metabotropic Glutamate Receptor 3 Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Metabotropic Glutamate Receptor 3 Market Size by Region (2020-2025) &nbsp;6.2 APAC Metabotropic Glutamate Receptor 3 Market Size by Type (2020-2025) &nbsp;6.3 APAC Metabotropic Glutamate Receptor 3 Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2020-2025) &nbsp;7.2 Europe Metabotropic Glutamate Receptor 3 Market Size by Type (2020-2025) &nbsp;7.3 Europe Metabotropic Glutamate Receptor 3 Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Metabotropic Glutamate Receptor 3 by Region (2020-2025) &nbsp;8.2 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Metabotropic Glutamate Receptor 3 Market Forecast &nbsp;10.1 Global Metabotropic Glutamate Receptor 3 Forecast by Region (2026-2031) &nbsp;10.1.1 Global Metabotropic Glutamate Receptor 3 Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.1.3 APAC Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.1.4 Europe Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.1.5 Middle East & Africa Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.2 Americas Metabotropic Glutamate Receptor 3 Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.2.2 Canada Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.2.3 Mexico Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.2.4 Brazil Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.3 APAC Metabotropic Glutamate Receptor 3 Forecast by Region (2026-2031) &nbsp;10.3.1 China Metabotropic Glutamate Receptor 3 Market Forecast &nbsp;10.3.2 Japan Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.3.3 Korea Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.3.4 Southeast Asia Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.3.5 India Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.3.6 Australia Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.4 Europe Metabotropic Glutamate Receptor 3 Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.4.2 France Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.4.3 UK Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.4.4 Italy Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.4.5 Russia Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.5 Middle East & Africa Metabotropic Glutamate Receptor 3 Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.5.2 South Africa Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.5.3 Israel Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.5.4 Turkey Market Metabotropic Glutamate Receptor 3 Forecast &nbsp;10.6 Global Metabotropic Glutamate Receptor 3 Forecast by Type (2026-2031) &nbsp;10.7 Global Metabotropic Glutamate Receptor 3 Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Metabotropic Glutamate Receptor 3 Forecast 11 Key Players Analysis &nbsp;11.1 Addex Therapeutics Ltd &nbsp;11.1.1 Addex Therapeutics Ltd Company Information &nbsp;11.1.2 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Product Offered &nbsp;11.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Addex Therapeutics Ltd Main Business Overview &nbsp;11.1.5 Addex Therapeutics Ltd Latest Developments &nbsp;11.2 Aevi Genomic Medicine Inc &nbsp;11.2.1 Aevi Genomic Medicine Inc Company Information &nbsp;11.2.2 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Product Offered &nbsp;11.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Aevi Genomic Medicine Inc Main Business Overview &nbsp;11.2.5 Aevi Genomic Medicine Inc Latest Developments &nbsp;11.3 Denovo Biopharma LLC &nbsp;11.3.1 Denovo Biopharma LLC Company Information &nbsp;11.3.2 Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Product Offered &nbsp;11.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Denovo Biopharma LLC Main Business Overview &nbsp;11.3.5 Denovo Biopharma LLC Latest Developments &nbsp;11.4 Domain Therapeutics SA &nbsp;11.4.1 Domain Therapeutics SA Company Information &nbsp;11.4.2 Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Product Offered &nbsp;11.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Domain Therapeutics SA Main Business Overview &nbsp;11.4.5 Domain Therapeutics SA Latest Developments &nbsp;11.5 Eli Lilly and Company &nbsp;11.5.1 Eli Lilly and Company Company Information &nbsp;11.5.2 Eli Lilly and Company Metabotropic Glutamate Receptor 3 Product Offered &nbsp;11.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Eli Lilly and Company Main Business Overview &nbsp;11.5.5 Eli Lilly and Company Latest Developments &nbsp;11.6 Prexton Therapeutics SA &nbsp;11.6.1 Prexton Therapeutics SA Company Information &nbsp;11.6.2 Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Product Offered &nbsp;11.6.3 Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Prexton Therapeutics SA Main Business Overview &nbsp;11.6.5 Prexton Therapeutics SA Latest Developments 12 Research Findings and Conclusion

Report	Global Metabotropic Glutamate Receptor 3 Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI23714

Buyer Information

Order Summary